Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Aligned heart rates indicate real-world social connection and engagement

23

Jun 2026

Aligned heart rates indicate real-world social connection and engagement

When people are close-both physically and emotionally-their heart rates begin to align, rising and falling together. Could such cardiac alignment be used as a way to measure social engagement and connection in everyday settings? Hanlu He and colleagues used data collected by 72 students visiting New York City as part of an audio engineering competition.

COPD patients lack critical health information during major wildfire events

23

Jun 2026

COPD patients lack critical health information during major wildfire events

Wildfire smoke can trigger breathing problems and flare-ups for people with chronic obstructive pulmonary disease (COPD), yet many people are not receiving the trusted health information they need to stay safe, according to a new study in the May 2026 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open access journal.

Scientists discover how food poisoning bacteria protect themselves from antibiotics

23

Jun 2026

Scientists discover how food poisoning bacteria protect themselves from antibiotics

Scientists from the Department of Microbiology of the University of Malaga, also members of the Institute of Subtropical and Mediterranean Horticulture 'La Mayora' (IHSM), have discovered a hitherto unknown mechanism that allows the bacterium Bacillus cereus, which is responsible for food poisoning and human infections, to protect itself against antibiotics and adverse conditions.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.